From October 1, 2022 to November 21, 2022, the company has repurchased 1,211,505 shares, representing 0.22% for CNY 55.98 million. With this, the company has completed the repurchase of 2,022,344 shares, representing 0.37% for CNY 100 million under the buyback announced on August 4, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17.41 CNY | -3.12% | +3.57% | -30.78% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-30.78% | 1.36B | |
+31.72% | 695B | |
+26.51% | 568B | |
-4.74% | 361B | |
+19.48% | 330B | |
+3.68% | 283B | |
+16.81% | 239B | |
+8.70% | 204B | |
-7.93% | 198B | |
+8.74% | 168B |
- Stock Market
- Equities
- 300363 Stock
- News Porton Pharma Solutions Ltd.
- Tranche Update on Porton Pharma Solutions Ltd.'s Equity Buyback Plan announced on August 4, 2022.